| CAS NO: | 1355631-24-1 |
| 包装 | 价格(元) |
| 10mM (in 1mL DMSO) | 电议 |
| 2mg | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
| 200mg | 电议 |
| 500mg | 电议 |
| Cas No. | 1355631-24-1 |
| 别名 | 5-氯-4-[(3,4-二氯苯氧基)甲基]-2-氟-N-(甲基磺酰基)苯甲酰胺 |
| Canonical SMILES | O=C(NS(=O)(C)=O)C1=CC(Cl)=C(COC2=CC=C(Cl)C(Cl)=C2)C=C1F |
| 分子式 | C15H11Cl3FNO4S |
| 分子量 | 426.67 |
| 溶解度 | DMSO: ≥ 100 mg/mL (234.37 mM); Water:< 0.1 mg/mL (insoluble) |
| 储存条件 | Store at -20°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
| 产品描述 | Nav1.7 inhibitor is a potent Nav1.7 inhibitor.IC50 value:Target: Nav1.7Preparation of sulfonamide derivatives as Nav1.7 inhibitorsBy Brown, Alan Daniel; Rawson, David James; Storer, Robert Ian; Swain, Nigel Alan From PCT Int. Appl. (2012), WO 2012007868 A2 20120119. [1]. Preparation of sulfonamide derivatives as Nav1.7 inhibitors. Patent WO 2012007868 A2 20120119 |
m.cnreagent.com